The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: Evidence from two independent cohorts

Journal of Medical Genetics

Volumn 42, Issue 11, 2005, Pages 852-856

  Fremeaux Bacchi, V ^b   Kemp, E J ^a   Goodship, J A ^a   Dragon Durey, M A ^b   Strain, L ^a   Loirat, C ^c   Deng, H W ^d   Goodship, T H J ^a,e  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^e Institute of Human Genetics   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; MEMBRANE COFACTOR PROTEIN;

ALLELE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; GENETIC SUSCEPTIBILITY; GENETICS; HAPLOTYPE; HEMOLYTIC UREMIC SYNDROME; HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANTIGENS, CD46; COHORT STUDIES; COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; DNA PRIMERS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, COMPLEMENT;

EID: 26944480588     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2005.030783     Document Type: Article

References (26)

1. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002;347:589-600.
2. Richards A, Goodship JA, Goodship THJ. The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thromboctyopenic purpura. Curr Opin Nephrol Hypertens 2002;11:431-5.
3. Warwicker P, Goodship THJ, Donne RL, Pirson Y, Nicholls A, Ward RM, Goodship JA. Genetic studies into inherited and sporadic haemolytic uraemic syndrome. Kidney Int 1998;53:836-44.
4. Ying L, Katz Y, Schlesinger M, Carmi R, Shalev H, Haider N, Beck G, Sheffield VC, Landau D. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am J Hum Genet 1999;65:1538-46.
5. Buddles MR, Donne RL, Richards A, Goodship J, Goodship TH. Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am J Hum Genet 2000;66:1721-2.
6. Richards A, Buddles MR, Donne RL, Kaplan BS, Kirk E, Venning MC, Tielemans CL, Goodship JA, Goodship THJ. Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J Hum Genet 2001;68:485-90.
7. Caprioli J, Bettinaglio P, Zipfel PF, Amadei B, Daina E, Gamba S, Skerka C, Marziliano N, Remuzzi G, Noris M. The molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol 2001;12:297-307.
8. Perez-Caballero D, Gonzalez-Rubio C, Gallardo ME, Vera M, Lopez-Trascasa M, Rodriguez de Cordoba S, Sanchez-Corral P. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet 2001;68:478-84.
9. Richards A, Kemp EJ, Liszewski MK, Goodship JA, Lampe AK, Decorte R, Muslumanoglu MH, Kavukcu S, Filler G, Pirson Y, Wen LS, Atkinson JP, Goodship TH. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Assoc Sci USA 2003;100:12966-71.
10. Noris M, Brioschi S, Caprioli J, Todeschini M, Bresin E, Porrati F, Gamba S, Remuzzi G. Familial haemolytic uraemic syndrome and an MCP mutation Lancet 2003;362:1542-7.
11. Dragon-Durey MA, Fremeaux-Bacchi V, Loirat C, Blouin J, Niaudet P, Deschenes G, Coppo P, Herman FW, Weiss L. Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J Am Soc Nephrol 2004;15:787-95.
12. Fremeaux-Bacchi V, Dragon-Durey M, Blouin J, Vigneau C, Kuypers D, Boudailliez B, Loirat C, Rondeau E, Fridman W. Complement factor I: a susceptibility gene for atypical hemolytic-uremic syndrome. J Med Genet 2004;41:e84.
13. Sanchez-Corral P, Perez-Caballero D, Huarte O, Simckes AM, Goicoechea E, Lopez-Trascasa M, Rodriguez De Cordoba S. Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. Am J Hum Genet 2002;71:1285-95.
14. Manuelian T, Hellwage J, Meri S, Caprioli J, Noris M, Heinen S, Jozsi M, Neumann HP, Remuzzi G, Zipfel PF. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest 2003;111:1181-90.
15. Ballermann BJ. Endothelial cell activation. Kidney Int 1998;53:1810-26.
16. Caprioli J, Castelletti F, Bucchioni S, Bettinaglio P, Bresin E, Pianetti G, Gamba S, Brioschi S, Daina E, Remuzzi G, Noris M. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G ana the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 2003;12:3385-95.
17. Esparza-Gordillo J, de Jorge EG, Buil A, Berges LC, Lopez-Trascasa M, Sanchez-Corral P, de Cordoba SR. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the Regulators of Complement Activation gene cluster in 1q32. Hum Mol Genet 2005;14:703-12.
18. Perkins SJ, Goodship THJ. Molecular modelling of the C-terminal domains of factor H of human complement. A correlation between haemolytic uraemic syndrome and a predicted heparin binding site. J Mol Biol 2002;316:217-24.
19. Donne RL, Abbs I, Barany P, Elinder CG, Little M, Conlon P, Goodship THJ. Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor. Am J Kidney Dis 2002;40:E22.
20. Olie KH, Florquin S, Groothoff JW, Verlaak R, Strain L, Goodship TH, Weening JJ, Davin JC. Atypical relapse of hemolytic uremic syndrome after transplantation. Pediatr Nephrol 2004;19:1173-6.
21. Filler G, Radhakrishnan S, Strain L, Hill A, Knoll G, Goodship TH. Challenges in the management of infantile factor H associated hemolytic uremic syndrome. Pediatr Nephrol 2004;19:908-11.
22. Rougier N, Kazatchkine MD, Rougier J-P, Fremeaux-Bacchi V, Blouin J, Deschenes G, Soto B, Baudouin V, Pautard B, Proesmans W, Weiss E, Weiss L. Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrol 1998;9:2318-26.
23. Nathanson S, Fremeaux-Bacchi V, Deschenes G. Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency. Pediatr Nephrol 2001;16:554-6.
24. Dragon-Durey MA, Loirat C, Cloarec S, Macher MA, Blouin J, Nivet H, Weiss L, Fridman WH, Fremeaux-Bacchi V. Anti-Factor H autoantibodies associated with atypical Hemolytic Uremic Syndrome. J Am Soc Nephrol 2004;16:555-63.
25. Jeanpierre M. A rapid method for the purification of DNA from blood. Nucleic Acids Res 1987;15:9611.
26. Warwicker P, Goodship THJ, Goodship JA. Three novel polymorphisms in the human complement factor H gene and promoter region. Immunogenetics 1997;46:437-8.